Nebraska Methodist Health System
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Nebraska Methodist Health System sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Nebraska Methodist Health System: 5 sponsored US clinical trials, 2 recruiting.
Nebraska Methodist Health System sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. 3 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension in Pregnancy, with 2 trials.
Upper-quartile sponsor footprint
Nebraska Methodist Health System sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
NCT07023003
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
NCT05309460
De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
NCT04638465
Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure
NCT07220902
Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site
NCT04880603
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Where Nebraska Methodist Health System enrollment is open (later-stage tilt)
2 recruiting of 5 indexed (40% open).
Phase mix: 3 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Hypertension in Pregnancy (2 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Nebraska Methodist Health System: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
Nebraska Methodist Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this Nebraska Methodist Health System page
5 registered trials is a research-attention snapshot, not an endorsement of Nebraska Methodist Health System or any single study.
- 2 of Nebraska Methodist Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension in Pregnancy is the condition Nebraska Methodist Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension in Pregnancy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Nebraska Methodist Health System pipeline card: 5 registered trials from official public datasets.Report a data error.